scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.JACC.2016.01.073 |
P698 | PubMed publication ID | 27126533 |
P50 | author | Ron Waksman | Q7364511 |
P2093 | author name string | Stephen E Epstein | |
Michael J Lipinski | |||
Robert O Bonow | |||
Edwin Wu | |||
Dror Luger | |||
Peter C Westman | |||
P433 | issue | 17 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | inflammation | Q101991 |
P304 | page(s) | 2050-2060 | |
P577 | publication date | 2016-05-01 | |
P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
P1476 | title | Inflammation as a Driver of Adverse Left Ventricular Remodeling After Acute Myocardial Infarction | |
P478 | volume | 67 |
Q90069019 | Association between Galectin-3 levels within central and peripheral venous blood, and adverse left ventricular remodelling after first acute myocardial infarction |
Q90633309 | Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart Failure |
Q42155507 | Associations between Left Ventricular Cavity Size and Cardiac Function and Overload Determined by Natriuretic Peptide Levels and a Covariance Structure Analysis. |
Q92210566 | Biological Scaffolds for Abdominal Wall Repair: Future in Clinical Application? |
Q64230003 | C-X-C Motif Chemokine Receptor 4 Blockade Promotes Tissue Repair After Myocardial Infarction by Enhancing Regulatory T Cell Mobilization and Immune-Regulatory Function |
Q95277553 | Cardiovascular Impairment in COVID-19: Learning From Current Options for Cardiovascular Anti-Inflammatory Therapy |
Q88523483 | Cardiovascular Magnetic Resonance in Acute ST-Segment-Elevation Myocardial Infarction: Recent Advances, Controversies, and Future Directions |
Q93349471 | Cathepsin K-deficiency impairs mouse cardiac function after myocardial infarction |
Q91512596 | Circulating plasma dipeptidyl dipeptidase 3 and the prognosis of cardiogenic shock |
Q50044861 | Cytosolic DNA Sensing Promotes Macrophage Transformation and Governs Myocardial Ischemic Injury |
Q37695032 | Defining left ventricular remodeling following acute ST-segment elevation myocardial infarction using cardiovascular magnetic resonance |
Q89428892 | Depression and Anxiety in Heart Failure: A Review |
Q58733328 | Effects of captopril and valsartan on ventricular remodeling and inflammatory cytokines after interventional therapy for AMI |
Q100464550 | Effects on cardiac function, remodeling and inflammation following myocardial ischemia-reperfusion injury or unreperfused myocardial infarction in hypercholesterolemic APOE*3-Leiden mice |
Q92233793 | Enhanced monocyte recruitment and delayed alternative macrophage polarization accompanies impaired repair following myocardial infarction in C57BL/6 compared to BALB/c mice |
Q90335075 | From Neutrophil Calcium Sensor to Myocardial Remodelling-A Double-Edged Pathway Guided by the Inflammasome |
Q59805634 | Galectin-1 as an Emerging Mediator of Cardiovascular Inflammation: Mechanisms and Therapeutic Opportunities |
Q90161278 | Genetic profiling of fatty acid desaturase polymorphisms identifies patients who may benefit from high-dose omega-3 fatty acids in cardiac remodeling after acute myocardial infarction-Post-hoc analysis from the OMEGA-REMODEL randomized controlled tr |
Q91106624 | Heart failure as interstitial cancer: emergence of a malignant fibroblast phenotype |
Q90683636 | IGF-1C domain-modified hydrogel enhanced the efficacy of stem cells in the treatment of AMI |
Q50168083 | Immune mechanisms in heart failure |
Q58793281 | Improvements in long standing cardiac pathologies by individualized homeopathic remedies: A case series |
Q90667609 | Inflammation and NLRP3 Inflammasome Activation Initiated in Response to Pressure Overload by Ca2+/Calmodulin-Dependent Protein Kinase II δ Signaling in Cardiomyocytes Are Essential for Adverse Cardiac Remodeling |
Q47734765 | Inflammation following acute myocardial infarction: Multiple players, dynamic roles, and novel therapeutic opportunities |
Q92524562 | Lack of resolution sensor drives age-related cardiometabolic and cardiorenal defects and impedes inflammation-resolution in heart failure |
Q64084650 | Low Density Lipoprotein Receptor-Related Protein-1 in Cardiac Inflammation and Infarct Healing |
Q90153772 | Matrix metalloproteinase-12 produced by Ly6Clow macrophages prolongs the survival after myocardial infarction by preventing neutrophil influx |
Q55230733 | Mechanisms responsible for increased circulating levels of galectin-3 in cardiomyopathy and heart failure. |
Q39223572 | Mesenchymal Stem Cell Therapy for the Treatment of Heart Failure Caused by Ischemic or Non-ischemic Cardiomyopathy: Immunosuppression and Its Implications |
Q64974312 | Molecular Imaging of Inflammation in Ischemic Heart Disease. |
Q92378330 | Molecular Imaging of the Heart |
Q52619556 | Myocardial Infarction Remodeling that Progresses to Heart Failure: A Signaling Misunderstanding. |
Q47902404 | Myocardial Infarction and Exercise Training: Evidence from Basic Science |
Q91594685 | Myocardial Injury After Ischemia/Reperfusion Is Attenuated By Pharmacological Galectin-3 Inhibition |
Q57177232 | Omega-3 Fatty Acid Supplementation and Cardiovascular Disease Risk: Glass Half Full or Time to Nail the Coffin Shut? |
Q36295418 | Osteoprotegerin levels in ST-elevation myocardial infarction: Temporal profile and association with myocardial injury and left ventricular function |
Q50027785 | Persistent Inflammation, Stem Cell-Induced Systemic Anti-Inflammatory Effects, and Need for Repeated Stem Cell Injections: Critical Concepts Influencing Optimal Stem Cell Strategies for Treating Acute Myocardial Infarction and Heart Failure |
Q91988023 | Phase 3 DREAM-HF Trial of Mesenchymal Precursor Cells in Chronic Heart Failure |
Q38638181 | Plasma IL-37 Elevated in Patients with Chronic Heart Failure and Predicted Major Adverse Cardiac Events: A 1-Year Follow-Up Study. |
Q92351043 | Potential of mesenchymal- and cardiac progenitor cells for therapeutic targeting of B-cells and antibody responses in end-stage heart failure |
Q48138711 | Pre-revascularization coronary wedge pressure as marker of adverse long-term left ventricular remodelling in patients with acute ST-segment elevation myocardial infarction |
Q98298303 | Regulatory T cells in ischemic cardiovascular injury and repair |
Q51627539 | Relation of inflammatory markers with myocardial and microvascular injury in patients with reperfused ST-elevation myocardial infarction. |
Q47682969 | Role of NLRP3 inflammasome in the pathogenesis of cardiovascular diseases |
Q91639887 | Salvia miltiorrhiza and Carthamus tinctorius Extract Prevents Cardiac Fibrosis and Dysfunction after Myocardial Infarction by Epigenetically Inhibiting Smad3 Expression |
Q46293355 | Sanggenon C protects against cardiomyocyte hypoxia injury by increasing autophagy |
Q90341456 | Specialized Pro-resolving Mediators Directs Cardiac Healing and Repair with Activation of Inflammation and Resolution Program in Heart Failure |
Q30490730 | Statistical shape modeling of the left ventricle: myocardial infarct classification challenge |
Q50125836 | Summed thickening score by myocardial perfusion imaging: A risk factor of left ventricular remodeling in patients with myocardial infarction |
Q90652581 | The IL-1β Antibody Gevokizumab Limits Cardiac Remodeling and Coronary Dysfunction in Rats With Heart Failure |
Q41308721 | The Matrikine Acetylated Proline-Glycine-Proline Couples Vascular Inflammation and Acute Cardiac Rejection |
Q45073088 | The NLRP3 inflammasome in acute myocardial infarction |
Q47662772 | Trajectories of Circulating Monocyte Subsets After ST-Elevation Myocardial Infarction During Hospitalization: Latent Class Growth Modeling for High-Risk Patient Identification. |
Q47677252 | Understanding cardiac extracellular matrix remodeling to develop biomarkers of myocardial infarction outcomes. |
Q90149907 | α1-AR overactivation induces cardiac inflammation through NLRP3 inflammasome activation |
Search more.